Skizofrénia: vizsgálatok itt: Kína
56 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1/2. fázisNot yet taking people in KínaXingqi Daozhi Decoction for Antipsychotic-Induced Constipation
- Where
- Shanghai
- Életkor
- 18 év to 65 év
- People
- 46
- Run by
- Shanghai Mental Health Center
See details and how to joinNCT07767526 - No phaseNot yet taking people in KínaTemporal Interference Stimulation Targeting Thalamus for Schizophrenia-Related Cognitive Dysfunction
- Where
- Changsha
- Életkor
- 18 év to 60 év
- People
- 80
- Run by
- Central South University
See details and how to joinNCT07927790 - 3. fázisTaking peopleSequential Treatment Approaches for Treatment-Resistant Schizophrenia
- Where
- Shanghai
- Életkor
- 18 év to 55 év
- People
- 300
- Run by
- Shanghai Mental Health Center
See details and how to joinNCT07918222 - 3. fázisNot yet taking people in KínaPhase 3 Study of HS-10380 for Acute Schizophrenia in Chinese Adults
- Where
- Shanghai
- Életkor
- 18 év to 65 év
- People
- 476
- Run by
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
See details and how to joinNCT07911787 - 1. fázisNot yet taking people in KínaPhase I Trial of HHK101 in Patients With Schizophrenia
- Where
- Changsha, Huzhou, Shanghai, Xi’an
- Életkor
- 18 év to 65 év
- People
- 88
- Run by
- Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd.
See details and how to joinNCT07815210 - No phaseTaking peopletACS for Working Memory in Schizophrenia
- Where
- Changsha
- Életkor
- 18 év to 50 év
- People
- 30
- Run by
- Central South University
See details and how to joinNCT07701343 - No phaseTaking peopleA Relation Between Craving Induction and Treatment Response in Deep Transcranial Magnetic Stimulation (dTMS) for Reducing Antipsychotic-induced Weight Gain in Schizophrenia
- Where
- Changsha
- Életkor
- 18 év to 60 év
- People
- 30
- Run by
- Second Xiangya Hospital of Central South University
See details and how to joinNCT07805980 - 3. fázisTaking peopleA Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Where
- Beijing, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Kunming, Nanjing, Ningbo, Shanghai, Shenzhen, Tianjin, Xi'an, Zhenjiang
- Életkor
- 55 év to 90 év
- People
- 406 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT06585787 · EU 2024-516363-92-00 - No phaseTaking peopleThe Safety and Effectiveness of dTMS for Reducing Antipsychotic-induced Weight Gain
- Where
- Changsha
- Életkor
- 18 év to 60 év
- People
- 60
- Run by
- Second Xiangya Hospital of Central South University
See details and how to joinNCT07795554 - No phaseNot yet taking people in KínaTemporal Interference Stimulation (TI) for Schizophrenia (SCZ)
- Where
- Hefei
- Életkor
- 18 év to 60 év
- People
- 100
- Run by
- Anhui Medical University
See details and how to joinNCT07887997 - 2. fázisTaking peopleA Study of Brenipatide in Adult Participants With Schizophrenia
- Where
- Changsha, Chengdu, Hangzhou, Suzhou, Tianjin, Wuhu, Xi’an, Zhumadian
- Életkor
- 18 év to 55 év
- People
- 450 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07410507 - No phaseCsak meghívásosBerberine in Treating Negative Symptoms of Schizophrenia: Clinical Efficacy and Mechanisms
- Where
- Tianjin
- Életkor
- 18 év to 60 év
- People
- 120
- Run by
- Tianjin Anding Hospital
See details and how to joinNCT07356765 - No phaseTaking peopletACS for Self-Other Boundary in Schizophrenia
- Where
- Hefei
- Életkor
- 18 év to 50 év
- People
- 100
- Run by
- Chunyan Zhu
See details and how to joinNCT07818668 - No phaseNot yet taking people in KínaMulti-target TMS for Schizophrenia Negative Symptoms
- Where
- Shanghai
- Életkor
- 16 év to 45 év
- People
- 64
- Run by
- Shanghai Mental Health Center
See details and how to joinNCT07559084 - No phaseNot yet taking people in KínaImproving Quality of Informal Care for People With Schizophrenia
- Where
- Chengdu
- Életkor
- 18 év and over
- People
- 228
- Run by
- Chinese University of Hong Kong
See details and how to joinNCT07781748 - No phaseTaking peopledACC-Targeted Temporal Interference for Negative and Cognitive Symptoms in Schizophrenia
- Where
- Shanghai
- Életkor
- 18 év to 65 év
- People
- 74
- Run by
- Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University
See details and how to joinNCT07658898 - No phaseTaking peopleEfficacy and Safety of Combo-stim Deep Brain Stimulation for Treatment-refractory Mental Disorders
- Where
- Shanghai
- Életkor
- 18 év to 65 év
- People
- 18
- Run by
- Shanghai Mental Health Center
See details and how to joinNCT06112067 - 1. fázisTaking peopleEvaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119
- Where
- Beijing, Xi’an
- Életkor
- 18 év to 65 év
- People
- 40
- Run by
- Vigonvita Life Sciences
See details and how to joinNCT06504290 - 3. fázisNot yet taking people in KínaA Study to Evaluate the Long-term Safety of HS-10380 in Patients With Schizophrenia
- Where
- Beijing
- Életkor
- 18 év to 65 év
- People
- 500
- Run by
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
See details and how to joinNCT07759869 - 3. fázisTaking peopleMetformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients
- Where
- Changsha, Dali, Xiangshan, Yueyang, Zhumadian
- Életkor
- 18 év to 65 év
- People
- 400
- Run by
- Central South University
See details and how to joinNCT07045142 - No phaseTaking peopleImmunoinflammatory State Detection and Multimodal Brain Imaging and Electrophysiologic Changes in Schizophrenia
- Where
- Changsha
- People
- 200
- Run by
- Central South University
See details and how to joinNCT06673966 - No phaseTaking peopleTIS for Improving Cognitive Impairment in Schizophrenia
- Where
- Changsha
- Életkor
- 18 év to 50 év
- People
- 50
- Run by
- Central South University
See details and how to joinNCT07647380 - 2. fázisNot yet taking people in KínaEvaluating Safety and Efficacy of VV119 in Acute Schizophrenia Adults
- Where
- Beijing
- Életkor
- 18 év to 65 év
- People
- 500
- Run by
- Vigonvita Life Sciences
See details and how to joinNCT07703956 - 1. fázisTaking peopleThe Purpose of This Study is to Determine the Safety, Tolerability, and Pharmacokinetics of Brexpiprazole Long-acting Injection Following a Single Administration in Healthy Subjects/Patients With Schizophrenia.
- Where
- Beijing
- Életkor
- 18 év to 65 év
- People
- 56
- Run by
- Sichuan Kelun Pharmaceutical Co.,Ltd.
See details and how to joinNCT06674694 - No phaseTaking peopleA 20-Year Follow-up of First Episode Psychosis: Longitudinal Effects of Early Treatment Strategies and Relapse
- Where
- Hong Kong
- Életkor
- 18 év to 65 év
- People
- 178
- Run by
- The University of Hong Kong
See details and how to joinNCT07616999